TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

CEFEPIME HYDROCHLORIDE

CEFEPIME HYDROCHLORIDE
Infectious Disease Approved 2007-06-18
8
Indications
--
Phase 3 Trials
18
Years on Market

Details

Status
Prescription
First Approved
2007-06-18
Routes
INJECTION
Dosage Forms
INJECTABLE

CEFEPIME HYDROCHLORIDE Approval History

Loading approval history...

What CEFEPIME HYDROCHLORIDE Treats

6 indications

CEFEPIME HYDROCHLORIDE is approved for 6 conditions since its original approval in 2007. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Pneumonia
  • Febrile Neutropenia
  • Urinary Tract Infection
  • Pyelonephritis
  • Skin and Skin Structure Infections
  • Intra-Abdominal Infection
Source: FDA Label

Drugs Similar to CEFEPIME HYDROCHLORIDE

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

CEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINER
CEFEPIME HYDROCHLORIDE
5 shared
SAMSON MEDCL
Shared indications:
PneumoniaFebrile NeutropeniaUrinary Tract Infection +2 more
CEFEPIME IN PLASTIC CONTAINER
CEFEPIME HYDROCHLORIDE
5 shared
Baxter
Shared indications:
PneumoniaFebrile NeutropeniaUrinary Tract Infection +2 more
CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER
CEFEPIME HYDROCHLORIDE
4 shared
B BRAUN
Shared indications:
PneumoniaFebrile NeutropeniaUrinary Tract Infection +1 more
AZACTAM
AZTREONAM
3 shared
Bristol-Myers Squibb
Shared indications:
Urinary Tract InfectionPyelonephritisPneumonia
AZTREONAM
AZTREONAM
3 shared
Pfizer
Shared indications:
Urinary Tract InfectionPyelonephritisPneumonia
CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER
CEFOXITIN SODIUM
3 shared
B BRAUN
Shared indications:
PneumoniaUrinary Tract InfectionIntra-Abdominal Infection
CEFOXITIN IN PLASTIC CONTAINER
CEFOXITIN SODIUM
3 shared
SAMSON MEDCL
Shared indications:
PneumoniaUrinary Tract InfectionIntra-Abdominal Infection
ARIKAYCE KIT
AMIKACIN SULFATE
2 shared
INSMED INC
Shared indications:
Intra-Abdominal InfectionUrinary Tract Infection
CEFUROXIME
CEFUROXIME
2 shared
Hikma
Shared indications:
PneumoniaUrinary Tract Infection
CLEOCIN PHOSPHATE
CLINDAMYCIN PHOSPHATE
2 shared
Pfizer
Shared indications:
PneumoniaSkin and Skin Structure Infections
DIFLUCAN
FLUCONAZOLE
2 shared
Pfizer
Shared indications:
Urinary Tract InfectionPneumonia
ERTAPENEM SODIUM
ERTAPENEM SODIUM
2 shared
ACS DOBFAR SPA
Shared indications:
Skin and Skin Structure InfectionsPyelonephritis
INVANZ
ERTAPENEM SODIUM
2 shared
Merck
Shared indications:
Skin and Skin Structure InfectionsPyelonephritis
MACRODANTIN
NITROFURANTOIN, MACROCRYSTALLINE
2 shared
ALMATICA
Shared indications:
Urinary Tract InfectionPyelonephritis
NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)
NITROFURANTOIN
2 shared
Novartis
Shared indications:
Urinary Tract InfectionPyelonephritis
TAZICEF
CEFTAZIDIME
2 shared
Pfizer
Shared indications:
PneumoniaUrinary Tract Infection
TYGACIL
TIGECYCLINE
2 shared
PF PRISM CV
Shared indications:
Skin and Skin Structure InfectionsPneumonia
AMOXICILLIN PEDIATRIC
AMOXICILLIN
1 shared
Teva
Shared indications:
Urinary Tract Infection
AMPICILLIN AND SULBACTAM
AMPICILLIN SODIUM
1 shared
EUGIA PHARMA SPECLTS
Shared indications:
Skin and Skin Structure Infections
AMPICILLIN SODIUM
AMPICILLIN SODIUM
1 shared
SAGENT PHARMS INC
Shared indications:
Urinary Tract Infection
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

CEFEPIME HYDROCHLORIDE FDA Label Details

Pro

Indications & Usage

Cefepime for injection is a cephalosporin antibacterial indicated for the treatment of the following infections caused by susceptible strains of the designated microorganisms: Pneumonia. Empiric therapy for febrile neutropenic patients. Uncomplicated and complicated urinary tract infections (including pyelonephritis). Uncomplicated skin and skin structure infections. Complicated intra-abdominal infections (used in combination with metronidazole) in adults. 1.1 Pneumonia Cefepime for injection is indicated in the treatment of pneumonia (moderate to severe) caused by susceptible strains of Strep...

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.